Literature DB >> 24940338

Enteroviruses as a possible cause of hypertension, dilated cardiomyopathy (DCM) and hypertensive heart failure (HHF) in South western Nigeria.

I O Okonko1, A A Adebiyi2, O S Ogah3, F D Adu4.   

Abstract

BACKGROUND: Human enteroviruses have long been associated with various diseases of man resulting into a wide range of acute symptoms involving the cardiac and skeletal muscles, central nervous system, pancreas, skin and mucous membranes.
OBJECTIVE: To assess the role of enteroviruses in the etiology of hypertension, DCM and HHF.
METHODS: We obtained stool specimens from 70 subjects comprising 65 patients and 5 controls and isolation was carried out on RD, L20B, HEp-2C and Vero cell lines and identified by neutralization with standard antisera (RIVM). Thirty-six enteroviruses were isolated and identified to be Coxsackieviruses-B5, A9, Echoviruses 1, 6, 7, 9, 11, 12, 22, 30 and Poliovirus type 1 and 3.
RESULTS: Three most frequently occurring enterovirus serotypes which constitute 60.0% of the 30 NPEV typed and 50.0% of all the isolates were Echoviruses, Coxsackie-B5-virus and Coxsackievirus-A9. Echoviruses constituted 50.0% of all the serotypes while Coxsackieviruses-B5 and A9 accounts for the 27.8 % and 5.6% respectively. Enteroviral isolation rate was higher in age groups 51 years and above. The percentage of study subjects who had Coxsackie-B5-viruses and echoviruses was significantly (P<0.05) higher in cases of hypertension, HHF and DCM than in control subjects. Coxackie-B5-virus, Echovirus-6 and Echovirus-11 were found in both study locations.
CONCLUSION: The findings of this study showed that Enteroviruses may likely be involved in the etiology of hypertension, DCM and HHF. Further studies would therefore be necessary for the prevention and control of these diseases.

Entities:  

Keywords:  Echoviruses; Enteroviruses; Etiology; coxsackieviruses; dilated cardiomyopathy (DCM); hypertension; hypertensive heart failure (HHF)

Mesh:

Year:  2013        PMID: 24940338      PMCID: PMC4056497          DOI: 10.4314/ahs.v13i4.34

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  40 in total

Review 1.  How robust is the evidence for viruses in the induction of type 1 diabetes?

Authors:  Margo Honeyman
Journal:  Curr Opin Immunol       Date:  2005-10-10       Impact factor: 7.486

2.  Decreased in vitro type 1 immune response against coxsackie virus B4 in children with type 1 diabetes.

Authors:  Susanne Skarsvik; Julia Puranen; Jarno Honkanen; Merja Roivainen; Jorma Ilonen; Hanna Holmberg; Johnny Ludvigsson; Outi Vaarala
Journal:  Diabetes       Date:  2006-04       Impact factor: 9.461

3.  Connecting the missing link between dilated cardiomyopathy and viral myocarditis: virus, cytoskeleton, and innate immunity.

Authors:  Yuichiro Maekawa; Maral Ouzounian; M Anne Opavsky; Peter P Liu
Journal:  Circulation       Date:  2007-01-02       Impact factor: 29.690

4.  Myocarditis and heart failure: need for better diagnostic, predictive, and therapeutic tools.

Authors:  Stephane Heymans
Journal:  Eur Heart J       Date:  2007-05-09       Impact factor: 29.983

5.  Presentation, patterns of myocardial damage, and clinical course of viral myocarditis.

Authors:  Heiko Mahrholdt; Anja Wagner; Claudia C Deluigi; Eva Kispert; Stefan Hager; Gabriel Meinhardt; Holger Vogelsberg; Peter Fritz; Juergen Dippon; C-Thomas Bock; Karin Klingel; Reinhard Kandolf; Udo Sechtem
Journal:  Circulation       Date:  2006-10-02       Impact factor: 29.690

6.  Viral persistence in the myocardium is associated with progressive cardiac dysfunction.

Authors:  Uwe Kühl; Matthias Pauschinger; Bettina Seeberg; Dirk Lassner; Michel Noutsias; Wolfgang Poller; Heinz-Peter Schultheiss
Journal:  Circulation       Date:  2005-09-19       Impact factor: 29.690

7.  Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis.

Authors:  Stephane Heymans; Matthias Pauschinger; Armando De Palma; Angela Kallwellis-Opara; Susanne Rutschow; Melissa Swinnen; Davy Vanhoutte; Fangye Gao; Raimund Torpai; Andrew H Baker; Elisabeth Padalko; Johan Neyts; Heinz-Peter Schultheiss; Frans Van de Werf; Peter Carmeliet; Yigal M Pinto
Journal:  Circulation       Date:  2006-07-31       Impact factor: 29.690

8.  Treatment of potentially life-threatening enterovirus infections with pleconaril.

Authors:  H A Rotbart; A D Webster
Journal:  Clin Infect Dis       Date:  2001-01-15       Impact factor: 9.079

9.  A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis.

Authors:  Alida L P Caforio; Fiorella Calabrese; Annalisa Angelini; Francesco Tona; Annalisa Vinci; Stefania Bottaro; Angelo Ramondo; Elisa Carturan; Sabino Iliceto; Gaetano Thiene; Luciano Daliento
Journal:  Eur Heart J       Date:  2007-05-09       Impact factor: 29.983

10.  5' terminal deletions in the genome of a coxsackievirus B2 strain occurred naturally in human heart.

Authors:  Nora M Chapman; Kyung-Soo Kim; Kristen M Drescher; Kuniyuki Oka; Steven Tracy
Journal:  Virology       Date:  2008-04-01       Impact factor: 3.616

View more
  2 in total

1.  Infections and non-communicable diseases that just refuse to go away.

Authors:  James K Tumwine
Journal:  Afr Health Sci       Date:  2013-12       Impact factor: 0.927

Review 2.  Emerging Viral Infections, Hypertension, and Cardiovascular Disease in Sub-Saharan Africa: A Narrative Review.

Authors:  Lily D Yan; Sarah S Matuja; Kevin J Pain; Margaret L McNairy; Anthony O Etyang; Robert N Peck
Journal:  Hypertension       Date:  2022-03-11       Impact factor: 9.897

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.